{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:32:16Z","timestamp":1782221536046,"version":"3.54.5"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.28380","type":"journal-article","created":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T21:30:11Z","timestamp":1634506211000},"page":"e2128380","source":"Crossref","is-referenced-by-count":16,"title":["Preferences for More or Less Health Care and Association With Health Literacy of Men Eligible for Prostate-Specific Antigen Screening in Australia"],"prefix":"10.1001","volume":"4","author":[{"given":"Kristen","family":"Pickles","sequence":"first","affiliation":[{"name":"University of Sydney, Sydney Health Literacy Lab, School of Public Health, Faculty of Medicine and Health, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura D.","family":"Scherer","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Colorado School of Medicine, Aurora"},{"name":"VA Denver Center for Innovation, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Cvejic","sequence":"additional","affiliation":[{"name":"University of Sydney, Sydney Health Literacy Lab, School of Public Health, Faculty of Medicine and Health, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolyn","family":"Hersch","sequence":"additional","affiliation":[{"name":"University of Sydney, Sydney Health Literacy Lab, School of Public Health, Faculty of Medicine and Health, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Barratt","sequence":"additional","affiliation":[{"name":"University of Sydney, Sydney Health Literacy Lab, School of Public Health, Faculty of Medicine and Health, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten J.","family":"McCaffery","sequence":"additional","affiliation":[{"name":"University of Sydney, Sydney Health Literacy Lab, School of Public Health, Faculty of Medicine and Health, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,10,12]]},"reference":[{"issue":"11","key":"zoi210825r2","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1037\/hea0000417","article-title":"Development of the medical maximizer-minimizer scale.","volume":"35","author":"Scherer","year":"2016","journal-title":"Health Psychol"},{"issue":"32","key":"zoi210825r3","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1200\/JCO.19.01411","article-title":"Role of patient maximizing-minimizing preferences in thyroid cancer surveillance.","volume":"37","author":"Evron","year":"2019","journal-title":"J Clin Oncol"},{"issue":"22","key":"zoi210825r4","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1200\/JCO.2015.61.6532","article-title":"National prostate cancer screening rates after the 2012 US Preventive Services Task Force recommendation discouraging prostate-specific antigen\u2013based screening.","volume":"33","author":"Drazer","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi210825r5","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1038\/s41598-018-22589-y","article-title":"Factors associated with prostate specific antigen testing in Australians: analysis of the New South Wales 45 and Up study.","volume":"8","author":"Nair-Shalliker","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"zoi210825r6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.juro.2013.04.119","article-title":"Early detection of prostate cancer: AUA guideline.","volume":"190","author":"Carter","year":"2013","journal-title":"J Urol"},{"issue":"18","key":"zoi210825r8","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate cancer: US Preventive Services Task Force recommendation statement.","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"zoi210825r9","article-title":"Preventing overdiagnosis: how to stop harming the healthy.","volume":"344","author":"Moynihan","year":"2012","journal-title":"BMJ"},{"issue":"4","key":"zoi210825r10","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv014","article-title":"Conceptualizing overdiagnosis in cancer screening.","volume":"107","author":"Marcus","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"zoi210825r11","doi-asserted-by":"publisher","first-page":"795","DOI":"10.6004\/jnccn.2018.7274","article-title":"PSA testing use and prostate cancer diagnostic stage after the 2012 US Preventive Services Task Force guideline changes.","volume":"17","author":"Magnani","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"zoi210825r12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/jnci\/djaa171","article-title":"Racial and ethnic variation in psa testing and prostate cancer incidence following the 2012 USPSTF recommendation.","volume":"113","author":"Kensler","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"zoi210825r14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007436","article-title":"What do you think overdiagnosis means: a qualitative analysis of responses from a national community survey of Australians.","volume":"5","author":"Moynihan","year":"2015","journal-title":"BMJ Open"},{"issue":"1","key":"zoi210825r15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227304","article-title":"Evaluating two decision aids for Australian men supporting informed decisions about prostate cancer screening: a randomised controlled trial.","volume":"15","author":"Pickles","year":"2020","journal-title":"PLoS One"},{"issue":"9","key":"zoi210825r16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025470","article-title":"Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review.","volume":"8","author":"Vernooij","year":"2018","journal-title":"BMJ Open"},{"issue":"1","key":"zoi210825r17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/0272989X19891181","article-title":"Medical maximizing-minimizing predicts patient preferences for high- and low-benefit care.","volume":"40","author":"Scherer","year":"2020","journal-title":"Med Decis Making"},{"issue":"6","key":"zoi210825r18","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1177\/0272989X18782199","article-title":"Medical maximizing-minimizing preferences predict responses to information about prostate-specific antigen screening.","volume":"38","author":"Scherer","year":"2018","journal-title":"Med Decis Making"},{"issue":"5","key":"zoi210825r19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11606-008-0520-5","article-title":"Validation of screening questions for limited health literacy in a large VA outpatient population.","volume":"23","author":"Chew","year":"2008","journal-title":"J Gen Intern Med"},{"issue":"4","key":"zoi210825r20","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1177\/0272989X20927700","article-title":"Eliciting medical maximizing-minimizing preferences with a single question: development and validation of the MM1.","volume":"40","author":"Scherer","year":"2020","journal-title":"Med Decis Making"},{"issue":"2","key":"zoi210825r21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1046\/j.1369-6513.2001.00140.x","article-title":"A measure of informed choice.","volume":"4","author":"Marteau","year":"2001","journal-title":"Health Expect"},{"issue":"1","key":"zoi210825r22","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/spco.2008.2.issue-1","article-title":"Reflecting on six decades of selective exposure research: progress, challenges, and opportunities.","volume":"2","author":"Smith","year":"2008","journal-title":"Soc Personal Psychol Compass"},{"key":"zoi210825r23","doi-asserted-by":"publisher","first-page":"f158","DOI":"10.1136\/bmj.f158","article-title":"Women\u2019s views on overdiagnosis in breast cancer screening: a qualitative study.","volume":"346","author":"Hersch","year":"2013","journal-title":"BMJ"},{"issue":"4","key":"zoi210825r24","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s12160-014-9679-7","article-title":"Information avoidance tendencies, threat management resources, and interest in genetic sequencing feedback.","volume":"49","author":"Taber","year":"2015","journal-title":"Ann Behav Med"},{"issue":"2","key":"zoi210825r25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/(ISSN)1099-0771","article-title":"Affect and decision making: a \u201chot\u201d topic.","volume":"19","author":"Peters","year":"2006","journal-title":"J Behav Decis Mak"},{"issue":"10","key":"zoi210825r26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016246","article-title":"How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial.","volume":"7","author":"Hersch","year":"2017","journal-title":"BMJ Open"},{"key":"zoi210825r27","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.1111\/j.1460-2466.2006.00287.x","article-title":"The functions of affect in health communications and in the construction of health preferences.","volume":"56","author":"Peters","year":"2006","journal-title":"J Commun"},{"issue":"4","key":"zoi210825r28","doi-asserted-by":"crossref","DOI":"10.17061\/phrp30342012","article-title":"Health literacy and disparities in COVID-19-related knowledge, attitudes, beliefs and behaviours in Australia.","volume":"30","author":"McCaffery","year":"2020","journal-title":"Public Health Res Pract"},{"issue":"4","key":"zoi210825r30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.007160","article-title":"Benefits and harms of hypertension and high-normal labels: a randomized experiment.","volume":"14","author":"Muscat","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"10","key":"zoi210825r31","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1001\/jamaoto.2018.1694","article-title":"Association of preferences for papillary thyroid cancer treatment with disease terminology: a discrete choice experiment.","volume":"144","author":"Nickel","year":"2018","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"zoi210825r32","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1097\/JU.0000000000000832.018","article-title":"MP12-18 Medical Minimizer-Maximizer Scale (MMS) and patient perceptions of results in a clinical setting.","volume":"203","author":"Murray","year":"2020","journal-title":"J Urol"},{"issue":"1","key":"zoi210825r33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0272989X17716672","article-title":"Debiasing health-related judgments and decision making: a systematic review.","volume":"38","author":"Ludolph","year":"2018","journal-title":"Med Decis Making"},{"key":"zoi210825r34","doi-asserted-by":"crossref","first-page":"j3879","DOI":"10.1136\/bmj.j3879","article-title":"Mapping the drivers of overdiagnosis to potential solutions.","volume":"358","author":"Pathirana","year":"2017","journal-title":"BMJ"},{"key":"zoi210825r1","volume-title":"Your Medical Mind: How to Decide What Is Right for You","author":"Groopman","year":"2011"},{"key":"zoi210825r13","first-page":"486","volume-title":"Nursing Diagnosis and Intervention","author":"O\u2019Connor","year":"1989"},{"key":"zoi210825r29","volume-title":"National Cervical Screening Program Monitoring Report 2020","author":"Australian Institute of Health and Welfare","year":"2020"},{"key":"zoi210825r7","unstructured":"National Health and Medical Research Council of Australia (NHMRC). PSA testing for prostate cancer in asymptomatic men. Updated March 2014. Accessed September 9. 2021. https:\/\/www.nhmrc.gov.au\/sites\/default\/files\/documents\/reports\/clinical%20guidelines\/men4d-psa-testing-asymptomatic.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2784814\/pickles_2021_oi_210825_1633035207.78686.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T02:30:54Z","timestamp":1725935454000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2784814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.28380","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,12]]}}}